Law360, New York (January 12, 2007, 12:00 AM ET) -- In its January 9, 2007 decision, the U.S. Supreme Court got 2007 off to a roaring start with its eagerly anticipated decision in MedImmune, Inc. v. Genentech, Inc. Although its full impact will not be known for several years as lower courts grapple with the decision, MedImmune could profoundly affect the way in which patent owners license their technology in the future and also promises a significant amount of additional litigation relating to both existing and future license agreements.
The case resolves a relatively discrete constitutional...
"MedImmune" Ushers In New Era Of Patent Litigation
To view the full article, take a free trial now.
